Immunocore Holdings plc

NasdaqGS:IMCR Stock Report

Mkt Cap: US$2.9b

Immunocore Holdings Future Growth

How is Immunocore Holdings forecast to perform in the next 1 to 3 years based on estimates from 9 analysts?

Future Growth Score

5/6

Future Growth Score 5/6

  • Earnings vs Savings Rate

  • Earnings vs Market

  • High Growth Earnings

  • Revenue vs Market

  • High Growth Revenue

  • Future ROE


65.9%

Forecasted annual earnings growth

Earnings and Revenue Growth Forecasts

NasdaqGS:IMCR - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20252813549614
12/31/2024229-714568
12/31/2023183-129139
9/30/2022102-55-49-48N/A
6/30/202267-92-79-78N/A
3/31/202241-119-102-101N/A
12/31/202127-132-97-96N/A
9/30/202127-111-101-100N/A
6/30/202128-100-81-79N/A
3/31/202130-84-60-57N/A
12/31/202030-74-64-61N/A
9/30/202028-81-71-66N/A
6/30/202027-88-111-106N/A
3/31/202027-97-117-114N/A
12/31/201926-104-107-103N/A
12/31/201824-72-20-17N/A
12/31/201714-49-79-61N/A
12/31/201616-23-43-37N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: IMCR is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2%).

Earnings vs Market: IMCR is forecast to become profitable over the next 3 years, which is considered above average market growth.

High Growth Earnings: IMCR is expected to become profitable in the next 3 years.

Revenue vs Market: IMCR's revenue (28.5% per year) is forecast to grow faster than the US market (7% per year).

High Growth Revenue: IMCR's revenue (28.5% per year) is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: IMCR is forecast to be unprofitable in 3 years.


Discover growth companies